Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.
about
Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concernsBCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesisHemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation.Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cellsInduction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XLLarge-scale production of red blood cells from stem cells: what are the technical challenges ahead?Red blood cell generation by three-dimensional aggregate cultivation of late erythroblasts.Bmi-1 Regulates Extensive Erythroid Self-RenewalSIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.Rh D blood group conversion using transcription activator-like effector nucleases.A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing CompoundsVariant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci.Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.Effect of Induced Pluripotent Stem Cell Technology in Blood BankingDNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation.Advances in understanding erythropoiesis: evolving perspectivesRecent advances in globin research using genome-wide association studies and gene editing.β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.Evaluation of the major royal jelly proteins as an alternative to fetal bovine serum in culturing human cell lines.Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36.Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cellsConcise review: stem cell-based approaches to red blood cell production for transfusion.Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii.FANCI-FANCD2 stabilizes the RAD51-DNA complex by binding RAD51 and protects the 5'-DNA end.Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiation.Hemoglobin genetics: recent contributions of GWAS and gene editing.Development of autologous blood cell therapies.Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility.Direct reprogramming of fibroblasts into skeletal muscle progenitor cells by transcription factors enriched in undifferentiated subpopulation of satellite cells.Flicking the switch: adult hemoglobin expression in erythroid cells derived from cord blood and human induced pluripotent stem cells.Molecular interactions governing host-specificity of blood stage malaria parasites.An Introduction to Erythropoiesis Approaches.In Vitro Erythroid Differentiation and Lentiviral Knockdown in Human CD34+ Cells from Umbilical Cord Blood.Direct lineage reprogramming: a useful addition to the blood cell research toolbox.Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies.
P2860
Q54889536-F2F6CA53-71AB-4DCF-B746-4A7E60F3FFA4Q54889537-4F15A9C8-6215-489E-9CC2-13A85CA12FB5Q54889640-011FB616-69E3-468F-8FEE-FF6C530B0743Q54889641-017DCE98-2AED-4E72-A720-F2B1A4D4E0A0Q54889645-8C2CEF51-B5C9-44FA-B1A9-A7E62FDD393CQ54889646-C3BE4D46-7D7C-41C2-8601-B4BD5ED5DFF6Q54896729-F5AB4370-1D75-4401-9DB4-CD0939A3E289Q54896730-8B612998-5F8F-4162-A7CB-71B0DBD31A83Q54896731-474F6F11-A93D-40DC-957C-61715E456C2D
P1343
Q27007110-EC95CCEF-18FF-4586-8D92-B2990DDA51F2Q28607483-16B29270-4479-4DFC-B690-8649778661FAQ33361527-8BF19F91-0340-4EEE-9B3B-1421A4219C52Q33722582-5B9EB061-8F06-49E7-92A0-32C00F62F388Q33947085-C73444A8-15B7-4580-8827-D3F949A0FF01Q34394559-2B40DAAE-86D9-430C-91A7-8D396BC93972Q34463668-68131B6D-D3D1-4808-A08A-1F8F73BEF50AQ34658807-C9B5A2BF-730E-495F-9AFD-9B9F8AD8ECADQ35098758-B19EA492-01D9-4B49-997F-818D035DADD6Q35754383-1C4686CA-5DC0-4801-9C56-573CFB4F52C6Q35788756-948F5B3B-E99B-44DE-8443-6C067743D3F1Q35813538-8952C1A8-14A8-4D1D-8E9F-249CAE180DA2Q35824056-3F2752B1-5EF0-484A-8382-F6D124C1B50AQ36285408-35990A56-FEFA-4F00-B95C-0D2A506341DDQ36450196-7C53DD22-13A5-41D8-B14F-850CBEFC308AQ36652029-624041EC-712A-4E53-9BBC-780C5FBCAF87Q36728573-DC6AAEA1-C2CD-4AE5-98AB-50D6FF03C319Q36765085-57754453-603C-4D76-9EA8-71CDFAAA97BAQ36803829-9265AEA3-5BA3-46F8-B1D2-AABA69ED9FE1Q36909465-D8464D79-1924-4B90-9E1D-ACFE8C10FB64Q36968324-391AD805-B959-4F78-8512-DA4E5BD41866Q37020886-0FE75F2D-CC70-4BB3-910A-F7251E9CCAD6Q37410109-D96584A9-0A62-469A-B0C9-B2C33DBCB828Q37562037-EA3AD5B9-CC76-4958-97C5-6C5C32C80E83Q37707911-0F6D7CFA-9BBD-4417-B373-70BCF25709A5Q38173213-2C3E6AC0-E371-41CE-8F35-4781C69CB18EQ38613674-CF7F081F-0660-44DF-BC22-FF0DE33F7660Q38742836-E345FCC2-599F-463B-9920-7E65FEB80803Q38787039-953D81DD-B141-4003-9841-D921E84FE7C9Q38875745-F4110FD2-CCFB-4F99-AE0F-D2C23E496417Q38877308-A196B25D-F82D-499D-9304-D428D6143582Q39292498-3715DDE4-284C-4A2B-ABFD-4101D9FBE50EQ40132263-F4A0D479-745E-44CA-8574-322DD394AF08Q41387531-689964C6-E13F-4820-98F7-A4268628640FQ42725966-6680F926-483B-4757-9052-3F8C7C04F410Q43167837-B41A43FA-D414-4E42-8D98-6927000A9A3FQ45071130-0C0A24BC-9D23-48B4-BFFA-E12558328310Q45071131-8219A715-00B3-40AF-9880-AE72422D6F72Q45862868-D1413007-A925-4920-B181-004F419E0421Q45875308-0D3F53C4-A78E-4E26-9DCD-E4EB55EDD901
P2860
Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Establishment of immortalized ...... ce enucleated red blood cells.
@ast
Establishment of immortalized ...... ce enucleated red blood cells.
@en
Establishment of immortalized ...... ce enucleated red blood cells.
@nl
type
label
Establishment of immortalized ...... ce enucleated red blood cells.
@ast
Establishment of immortalized ...... ce enucleated red blood cells.
@en
Establishment of immortalized ...... ce enucleated red blood cells.
@nl
prefLabel
Establishment of immortalized ...... ce enucleated red blood cells.
@ast
Establishment of immortalized ...... ce enucleated red blood cells.
@en
Establishment of immortalized ...... ce enucleated red blood cells.
@nl
P2093
P2860
P4510
P1433
P1476
Establishment of immortalized ...... ce enucleated red blood cells.
@en
P2093
Hiroyuki Miyoshi
Kazuhiro Sudo
Kenichi Miharada
Kenzaburo Tani
Noriko Suda
Ryo Kurita
Takashi Hiroyama
Yukio Nakamura
P2860
P304
P356
10.1371/JOURNAL.PONE.0059890
P407
P4510
P577
2013-03-22T00:00:00Z